We have seen multiple 8-K filed, we have seen PRs
Post# of 36537
I know people say, well it's the OTC.
That's not really a valid argument, especially when you have CYDY sitting at 4.57 and it is down .24 and still that high.
GNBT is at .42! .42! A year ago July GNBT was at 3.28. There is a problem here. We have had CCs from the CEO who says he does more CCs than any other CEO in the world. And the PPS still goes down.
We have had PRs saying this or that and the PPS still goes down.
We have had all these deals and the PPS still goes down.
We have had a lot of things said and the PPS still goes down.
It's not the OTC. It's not even COVID. This all started before COVID, COVID just made things a bit worse.
Bad deals, 'bad actors', repeating the same mistakes, not following up with the SEC, bad documentation, the list goes on.
This is about management. It's that simple.
It's been discussed on here alot. Management either needs to get their act together now, not tomorrow, but now, or there needs to be a complete change in management starting from the top.
Generex / NGIO has the products, it's the management in question.